A 55-year-old man with a chief complaint of melena had diffusely infiltrated lymphoma from the rectum to the sigmoid colon and polyclonal hypergammaglobulinemia. Biopsy specimen obtained from the rectum revealed diffuse medium-sized lymphomacell with plasmocytosis. Histochemical analysis with monoclonal antibodies indicated that the origin of the tumor cell to be T-lymphocyte. Chemotherapy with cyclophosphamide, vincristine and prednisolone (VEP regimen) was effective for mucosal bleeding of the colonic lesion and reduction of polyclonal hypergammaglobulinemia.
Oneof the most common sites involved in extranodal lymphoma is known to be the gastrointestinal tract. Of the lymphomas which originate in the gastrointestinal system, however, colonic lymphoma is far less commoncompared to gastric or small intestinal involvement (1) . Tumor cells in primary gastrointestinal lymphomaare usually comprised of the B-cell type (2) . Here, a rare case of diffuse infiltrating T-cell lymphomaof the colon associated with polyclonal hypergammaglobulinemia and hepatocellular carcinoma is described.
CASE REPORT
A 55-year-old male was admitted in February 1983 to the sanatorium division of Hokkaido Prefectural Sapporo Kitano Hospital with a diagnosis of recurrent pulmonary tuberculosis. After 5 months of chemotherapy with isoniazid and ethumbutol hydrochloride for pulmonary tuberculosis, he noticed a melena with lower abdominal discomfort, and was referred to our gastrointestinal division.
Laboratory data revealed moderate anemia, positive occult blood and polyclonal hypergammaglobulinemia as shown in Table 1 . Sigmoidoscopic findings showed diffusely thickened rugous folds and ulcers in the rectum (Fig.  1) . Although Table 1 . Laboratory findings on first admission.
of tumor cells revealed positive staining with MT-1 monoclonal antibody but not with MB-1 or L-26 antibodies (Fig. 3) . These findings defined the tumor cells to be of T-cell origin (3, 4) . Because of his pulmonary disease, surgical treatment of the lymphomalesion was considered unsafe. He was treated with a regimen of cyclophosphamide, vincristine and prednisolone (VEP chemotherapy).
Following 10 courses of VEP administration, hypergammaglobulinemia and melena improved, and he was discharged from the sanatorium on September 10, 1984 . During 4 yrs of care in our outpatient clinic, he sometimes suffered from high fever, easy fatigability and pulmonary infections which were well controlled by appropriate medications. In the middle of May 1988, he again began to develop anemia and fever, and was admitted to our gastrointestinal division on May 31, 1988. Occult blood and hypergammaglobulinemia also recurred. In addition, elevation of alphafetoprotein (AFP) was newly evident at this time. Examination of abdominal ultrasonography revealed hypoechoic mass with a diameter of 2.7 x3.1 cm at the surface of the right lobe of the liver with heterogeneous distribution of increased echogenicity and diminished visualization of the vessel walls (Fig. 4) . The newly disclosed echopattern and the elevation of AFP strongly suggested the development of hepatocellular carcinoma (HCC) and fatty degeneration of liver parenchymal cells. Barium enemaexamination of the large intestine exhibited diffuse fine ulcerations with marginal speculation and loss of haustration from the rectum to the sigmoid colon. Howeverno obvious tumors were observed in the entire colon (Fig. 5 ).
About 3 months after his second admission, approximately 1 ,200 ml of anal bleeding followed by hypovolemic shock occurred. Rectosigmoidoscopic examination was performed (Fig. 6a) specimen of the rectum revealed the same histological findings as those in 1983. We diagnosed it to be recurrence of the lymphoma. Chemotherapy using the VEPregimen plus adriamycin was effective for controlling the mucosal bleeding from the colonic lesion (Fig. 6b) Intestinal lymphomahas been categorized into two groups, localized and diffuse types (7, 8) , and the former is more commonthan the latter. Only 12 cases of diffuse infiltrating malignant lymphoma of the colon have been previously reported (8-15).
Recent development of immunohistochemical analyse using monoclonal antibodies allows characterization of the origin of lymphomacells to be of T-cell or B-cell lineage (16). This classification by surface markers is very important in relation to the prognosis of the disease (2) . In general, the remission rate by chemotherapyor the survival period is better in patients with B-cell lymphoma than in those of T-cell lymphoma. The tumor cells of our patient were immunohistochemically stained be of T-lymphocyte lineage (3, 4) . The majority of lymphomas in the large intestine are reported to be B-cell type. Only two cases of T-cell lymphomahave been previously reported (17, 18) . In this regard, the present case with diffuse infiltrating large intestinal lymphoma was considered to be extremely rare. Polyclonal activation of B-lymphocytes has been frequently observed in patients with immunoblastic lymphadenopathy (IBL) (19). Recently Shimoyama et al reported similar hypergammaglobulinemia in patients with T-cell lymphomaand designated it as IBL-like T-cell lymphoma (20). The mechanism of hyper-reaction of the humoral immunesystem in patients with T-cell lymphomais not clear. However, the production of biologically active factors such as IL-6 or other lymphokines from tumor cells has been speculated (21). The present patient had polyclonal hypergammaglobulinemia and localized T-cell infiltration with plasmocytosis at large intestine and yet no superficial lymphadenopathywas observed at all, suggesting that lymphomacells in the colon were responsible for this phenomenonpossibly by producing the biologically active factors. Although manymalignancies are knownto be associated with non-Hodgkin's lymphoma (NHL), only ll patients have been reported to develop hepatocellular carcinoma (HCC) (22) (23) (24) (25) (26) (27) (28) (29) (30) . Six cases were diagnosed as synchronous double primary neoplasmas. Metachronous NHL subsequent to
HCCwas observed in 1 case. Four patients with NHL followed by HCC have been reported. All of these patients underwent chemotherapy for NHL prior to the development of HCC (25, 26, 28, 29 
